The old charge that psychodynamic therapy is untested and the new enthusiasm that it is the best of all therapies are both overstated. The strongest evidence is quieter than either: it works for common problems, it helps in serious ones, and the loudest arguments are about its edges.
The core science is now settled: modern psychodynamic therapy is effective for common disorders, and mentalization-based treatment reduces self-harm in borderline personality disorder. What remains mixed sits at the edges: how it compares head-to-head with CBT, whether its benefits truly keep growing after therapy, and whether insight is the real mechanism. A third set of questions, about its older unevidenced reputation, whether long-term analysis is justified, and allegiance bias on all sides, is genuinely contested, and honest sources present these as open debates rather than solved problems.
How psychodynamic therapy is studied
To judge which claims are strong and which are shaky, it helps to know where the evidence comes from. Research on psychodynamic therapy draws on several independent lines of study, and the claims that are settled tend to be the ones where these different methods point the same way.
Randomised controlled trials
People are assigned at random to psychodynamic therapy or a comparison, and outcomes are measured. Manualised treatments such as MBT and short-term dynamic therapy have made this method usable for an approach once thought too individual to test.
Meta-analyses
Reviews such as those by Shedler and by Leichsenring and Rabung pool many studies to estimate overall effect sizes, giving a more reliable picture than any single trial and revealing patterns like the growth of benefits over time.
Comparative trials
Studies that pit psychodynamic therapy directly against another therapy, usually CBT, test whether one genuinely outperforms the other. These are where allegiance bias and questions of equivalence come sharply into view.
Process research
Rather than only asking whether therapy works, process studies examine how, tracking insight, the therapeutic relationship, and specific techniques to test which ingredients actually drive change.
No single study settles anything on its own. Confidence comes from convergence: when trials, meta-analyses, and process research line up, a claim is on firm ground. Where they conflict or run short, honesty requires calling the question open.
Settled: what the evidence firmly supports
These claims are backed by modern trials and meta-analyses and are not seriously disputed among mainstream psychotherapy researchers. They represent the ground that the past two decades of research have genuinely secured.
Modern psychodynamic therapy is effective for common disorders. Meta-analyses and randomised trials support its use for depression and anxiety, with effect sizes broadly comparable to those of other established therapies. Jonathan Shedler's 2010 review in American Psychologist summarised this evidence, and a Cochrane review found benefit for short-term psychodynamic psychotherapy in common mental disorders. Saying it works does not mean it is best for every problem, only that its effectiveness for these conditions is well founded.
Mentalization-based treatment reduces self-harm in borderline personality disorder. MBT, a structured psychodynamic treatment developed by Bateman and Fonagy, has been tested in randomised controlled trials and shown to reduce self-harm and suicidal behaviour and to improve functioning, with benefits maintained at follow-up in some studies. This is among the strongest evidence for any psychodynamic approach, and it demonstrates that the tradition, put into a structured and testable form, produces measurable benefit for a serious condition.
The unevidenced reputation is out of date as a blanket claim. It was once fair to say psychodynamic therapy lacked controlled evidence, but that is no longer accurate across the board. A body of trials and meta-analyses now exists. Doubt about the older, intensive forms is reasonable, but the sweeping statement that psychodynamic therapy has no evidence has not survived the research of the past twenty years, and mainstream reviews treat it as an evidence-based approach for the conditions where it has been properly studied.
Mixed or evolving: where the science is still moving
These questions are actively researched and partly answered, but the evidence is incomplete, the estimates move with method, or the data are still thin. Here the honest posture is confidence about the broad shape and caution about the details.
How it compares head-to-head with CBT. Direct comparisons and meta-analyses generally find no large or consistent difference between psychodynamic therapy and CBT for common conditions; both tend to help. But the comparison is complicated by uneven trial numbers, varying quality, and allegiance effects on both sides. Whether the two are genuinely equivalent, or whether one has a real edge for particular problems, is not fully resolved, and confident claims of superiority in either direction outrun the current data.
Whether benefits truly keep growing after therapy ends. Several studies, highlighted in Shedler's review, report that gains from psychodynamic therapy increase at follow-up, a striking and appealing finding. It fits the theory that the approach sets in motion an ongoing capacity for self-reflection. But it rests on a limited set of studies, follow-up samples shrink and can be selective, and the pattern is not observed uniformly. The finding is real where reported but should be held with care rather than treated as a guarantee.
Whether insight is the mechanism of change. Psychodynamic theory holds that understanding one's patterns, and feeling them clearly, drives improvement. There is supportive process evidence, but researchers debate how central insight really is compared with common factors such as the therapeutic relationship and the expectation of help, which operate across all effective therapies. Whether insight is necessary, sufficient, or one ingredient among several is still being worked out, and the answer bears on what makes the therapy work at all.
Contested: where serious people genuinely disagree
These are not questions with a hidden right answer that one side refuses to see. They are real debates, shaped by values, definitions, and imperfect data, where thoughtful researchers reach different conclusions. This page does not take a side on them; it describes the disagreement.
Whether long-term, intensive analysis is justified. Some meta-analyses, notably Leichsenring and Rabung's work on long-term psychodynamic therapy, argue it benefits complex and chronic difficulties beyond what shorter treatments achieve. Critics have challenged those analyses on methodological grounds, including how studies were selected and compared. The briefer forms have far more controlled evidence than the intensive, multi-year classical analysis. Whether the extra time and cost of long-term work are warranted for most people is genuinely disputed and not resolved by the current data.
Allegiance and publication bias on all sides. Therapy trials tend to favour whichever approach the researchers running them prefer, an allegiance effect that muddies comparisons between psychodynamic therapy and its rivals. Both camps accuse the other of it, and both have some case. Publication patterns, where positive results are more likely to appear, add further distortion. Disentangling a therapy's true effect from the enthusiasm of its advocates is genuinely hard, and how much bias remains in the comparative literature is itself debated.
The legacy of the older reputation. Psychodynamic therapy still carries the reputation, earned in the twentieth century, of being unscientific and unproven. Its defenders argue this reputation is now unjust and lingers mainly because rivals built trial evidence faster. Its critics reply that scepticism about the more speculative parts of the tradition, and about its most intensive forms, remains warranted. How much of the old criticism should still apply to modern, evidence-based psychodynamic practice is a live and value-laden disagreement.
A common misreading
Because the contested questions are real and the history is genuinely mixed, it is tempting to conclude either that the whole approach is discredited or that all criticism is outdated prejudice. Both are the mistakes to avoid.
Because psychodynamic therapy was once criticised as unevidenced, it must still be pseudoscience.
The old criticism applied to a field that had not yet submitted to controlled trials. That has changed: modern psychodynamic therapy has real meta-analytic and trial support for common disorders and for borderline personality disorder. Legitimate debate continues about its long-term forms and its mechanisms, but treating the whole approach as discredited ignores two decades of evidence. Active disagreement about the edges of a therapy is normal, not a sign that it is fraudulent.
Reading psychodynamic claims critically
Most misleading coverage does one of two things: it takes the settled core and pretends it is still in doubt, or it takes a contested question and reports it as though it were settled. A few habits help you tell the difference.
Ask which pile the claim belongs in. A statement that psychodynamic therapy has no evidence is arguing against settled research. A claim that it definitively beats CBT, or that long-term analysis is proven best, treats a mixed or contested question as though it were closed. Notice whether a source distinguishes the well-supported briefer forms from the more speculative intensive ones, whether it acknowledges allegiance bias, and whether it cites the weight of evidence or a single favourable study. The honest state of the science is neither dismissive nor triumphant, and the more balanced the source, the closer it usually is to the truth.
Where to go next
If this page has mapped the evidence, the other pages fill in the detail. Start with the overview for what the therapy is, read effectiveness for how well it works, and see applications for the conditions it is used for.
Sources
- Shedler J. The Efficacy of Psychodynamic Psychotherapy. American Psychologist. 2010;65(2):98-109.
- Leichsenring F, Rabung S. Effectiveness of Long-term Psychodynamic Psychotherapy: A Meta-analysis. JAMA. 2008;300(13):1551-1565.
- Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database of Systematic Reviews. 2014;(7):CD004687.
This page is educational and is not medical advice. It does not diagnose any condition. Evidence describes averages across groups, not the certainty of any one person's outcome. If you are struggling with your mental health, speak with a qualified professional about which approach is right for you.